Sanofi, AstraZeneca and Sobi’s Streamlining of Nirsevimab Contractual Arrangements

Pietro Martinoia
Tagged:

Latham & Watkins represented Sobi in the transaction.Sanofi has simplified its contractual arrangements relating to the development and commercialization of Beyfortus (nirsevimab) in the United States…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now